PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not stated
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
This is a single-center, double-arm, open-label, randomized feasibility study that will determine whether a novel clinical decision aid accessed via the electronic health record will be acceptable to both cancer survivors and their cardiologists, will favorably impact appropriate medication use and cardiac imaging surveillance, and will improve clinician and patient decision-making, perception, and behavior towards cardioprotective medication usage and cardiovascular disease imaging utilization.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: 1. Patients ≥18 years with a history of cancer. 2. Have not previously visited a cardiologist to assess cardiovascular risk after cancer diagnosis. 3. Clinically at intermediate, high, or very high risk for cardiovascular diseases determined based on imprecise clinical risk models, such as those used for cardiac dysfunction. 4. Ability to understand a written informed consent form, and willing to sign it prior to study registration. Exclusion Criteria: 1. Patient \<18 years. 2. Without a personal history of cancer. 3. Existing cardiomyopathy diagnosed after cancer diagnosis. 4. Documented cognitive impairment. 5. Patient or patient representative who is unable and unwilling to sign the informed consent form.
Study sites (1)
WI
- Froedtert & the Medical College of Wisconsin · Milwaukee, WI 53226Yee Chung Chen, MD · Principal investigatorMore trials in Milwaukee